Literature DB >> 7698116

Dormancy of Mycobacterium tuberculosis and latency of disease.

L G Wayne1.   

Abstract

There is ample circumstantial evidence from observation of the natural history of tuberculosis in humans and experimental animals that Mycobacterium tuberculosis is capable of adapting to prolonged periods of dormancy in tissues, and that these dormant bacilli are responsible for latency of the disease itself. Furthermore, the dormant bacilli are resistant to killing by antimycobacterial agents. A systematic evaluation of the mechanism of dormancy, and of attempts to abrogate latency will require a better understanding of the physiologic events that attend the shiftdown into dormancy. There are probably two or more stages in the shiftdown of Mycobacterium tuberculosis from active replication to dormancy as bacilli in unagitated cultures settle through a self-generated O2 gradient into a sediment where O2 is severely limited. One step involves a shift from rapid to slow replication. The other involves complete shutdown of replication, but not death. Presumably this last step includes completion of a round of DNA synthesis. The shiftup on resumption of aeration includes at least three discrete sequential steps, the production of RNA, the ensuing synchronized cell division and, finally, the initiation of a new round of synthesis of DNA. Three markers of the process of shiftdown of Mycobacterium tuberculosis to dormancy have been described, namely the changes in tolerance to anaerobiosis, the production of a unique antigen and the ten-fold increase in glycine dehydrogenase production. Additional markers represented in the shiftup and shiftdown process may yet be discovered, and determination of their specific functions should provide insights into the mechanisms of dormancy and latency in tuberculosis, and into strategies for preventing reactivation of the bacilli and development of disease.

Entities:  

Mesh:

Year:  1994        PMID: 7698116     DOI: 10.1007/bf02111491

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  36 in total

1.  Enzyme systems in the mycobacteria. XIII. Glycine dehydrogenase and the glyoxylic acid cycle.

Authors:  D S GOLDMAN; M J WAGNER
Journal:  Biochim Biophys Acta       Date:  1962-12-04

2.  Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice.

Authors:  J L SEVER; G P YOUMANS
Journal:  Am Rev Tuberc       Date:  1957-10

3.  The clinicopathologic significance of the demonstration of viable tubercle bacilli in resected lesions.

Authors:  O AUERBACH; G L HOBBY; M J SMALL; T F LENERT; J V COMER
Journal:  J Thorac Surg       Date:  1955-02

4.  Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.

Authors:  L G Wayne; G A Diaz
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

5.  A mouse model of the recrudescence of latent tuberculosis in the elderly.

Authors:  I M Orme
Journal:  Am Rev Respir Dis       Date:  1988-03

6.  Synchronized replication of Mycobacterium tuberculosis.

Authors:  L G Wayne
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

7.  Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1976-10

8.  Experimental study on the relapse of tuberculosis after the termination of antituberculous chemotherapy using immunodeficient nude mice.

Authors:  M Toyohara
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

9.  Control of tuberculosis in the United States. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1992-12

10.  [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].

Authors:  J Grosset; C Truffot; J Fermanian; H Lecoeur
Journal:  Pathol Biol (Paris)       Date:  1982-06
View more
  116 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines.

Authors:  A D Howard; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  The stringent response of Mycobacterium tuberculosis is required for long-term survival.

Authors:  T P Primm; S J Andersen; V Mizrahi; D Avarbock; H Rubin; C E Barry
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

Review 4.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

6.  Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Authors:  L E Desjardin; L G Hayes; C D Sohaskey; L G Wayne; K D Eisenach
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  Metronidazole therapy in mice infected with tuberculosis.

Authors:  J V Brooks; S K Furney; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

8.  Cl- channels in basolateral TAL membranes. XIX. Cytosolic Cl- regulates mmCIC-Ka and mcCIC-Ka channels.

Authors:  C J Winters; M V Mikhailova; T E Andreoli
Journal:  J Membr Biol       Date:  2003-09-15       Impact factor: 1.843

9.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

10.  Analysis of expression profile of mammalian cell entry (mce) operons of Mycobacterium tuberculosis.

Authors:  Ashwani Kumar; Mridula Bose; Vani Brahmachari
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.